|
ANKMY2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.004700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.289760E-01 |
| Normal-vs-Stage2 |
4.611600E-01 |
| Normal-vs-Stage3 |
3.21350000054288E-07 |
| Normal-vs-Stage4 |
2.205600E-04 |
| Stage1-vs-Stage2 |
9.146600E-01 |
| Stage1-vs-Stage3 |
5.63209999999703E-05 |
| Stage1-vs-Stage4 |
2.799100E-03 |
| Stage2-vs-Stage3 |
1.559660E-02 |
| Stage2-vs-Stage4 |
4.172300E-02 |
| Stage3-vs-Stage4 |
7.285000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.601300E-04 |
| Normal-vs-AfricanAmerican |
5.321400E-01 |
| Normal-vs-Asian |
8.466200E-01 |
| Caucasian-vs-AfricanAmerican |
2.537400E-01 |
| Caucasian-vs-Asian |
3.999000E-01 |
| AfricanAmerican-vs-Asian |
8.819200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.245800E-04 |
| Normal-vs-Female |
4.690400E-02 |
| Male-vs-Female |
1.803200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.086600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.367590E-02 |
| Normal-vs-Age(61-80Yrs) |
1.101520E-03 |
| Normal-vs-Age(81-100Yrs) |
5.400700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.261800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.428200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.455200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.014400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.772200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.163000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.967200E-01 |
| Normal-vs-Grade 2 |
2.852000E-01 |
| Normal-vs-Grade 3 |
1.800710E-04 |
| Normal-vs-Grade 4 |
4.42189951321836E-10 |
| Grade 1-vs-Grade 2 |
5.120600E-01 |
| Grade 1-vs-Grade 3 |
1.918030E-01 |
| Grade 1-vs-Grade 4 |
3.308300E-02 |
| Grade 2-vs-Grade 3 |
3.100000E-03 |
| Grade 2-vs-Grade 4 |
5.52640000428539E-09 |
| Grade 3-vs-Grade 4 |
1.059820E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.261400E-01 |
| Normal-vs-ccB subtype |
1.189970E-04 |
| ccA subtype-vs-ccB subtype |
4.798000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.579900E-03 |
| Normal-vs-N1 |
1.923660E-02 |
| N0-vs-N1 |
1.105020E-01 |
|
|
